Vigilant Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-105
Closed -$2K 477
2023
Q1
$2K Hold
105
﹤0.01% 426
2022
Q4
$3K Sell
105
-1
-0.9% -$26 ﹤0.01% 477
2022
Q3
$2K Sell
106
-105
-50% -$3.17K ﹤0.01% 553
2022
Q2
$7K Hold
211
﹤0.01% 479
2022
Q1
$7K Sell
211
-521
-71% -$17.8K ﹤0.01% 491
2021
Q4
$22K Buy
732
+128
+21% +$4.17K ﹤0.01% 393
2021
Q3
$20K Sell
604
-5
-0.8% -$160 ﹤0.01% 364
2021
Q2
$18K Buy
+609
New +$20K ﹤0.01% 343

Other funds holding OGN

Vigilant Capital Management's OGN Position: Q2 2023 in Review

Vigilant Capital Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 105 shares — an estimated $2K sold.

Vigilant Capital Management first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $22K in Q4 2021. 727 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Vigilant Capital Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Vigilant Capital Management sold 105 Organon & Co shares in Q2 2023, an estimated $2K.
  • Vigilant Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Vigilant Capital Management's Organon & Co position peaked at $22K in Q4 2021.
  • 727 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.